SpyGlass Pharma SGP
NASDAQ SGP
$34.18 -4.19 (-10.92%)
At close: Nov 10, 2026 · 4:00 PM EST

SpyGlass Pharma (SGP) Liabilities and Shareholders Equity (2024 - 2026)

Updated

SpyGlass Pharma's Liabilities and Shareholders Equity was $243.43 million in Q2 2026.

Analysis

SpyGlass Pharma (SGP) Liabilities and Shareholders Equity (2024 - 2026) Analysis & Trends

At the end of FY2025, Liabilities and Shareholders Equity at SpyGlass Pharma came in at $115.87 million, up 396.9% from FY2024.

  • In earlier years, Liabilities and Shareholders Equity was $23.32 million in FY2024.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Liabilities and Shareholders Equity (Qtr)
1 Eli Lilly 1,264.65 Bn 1,238.27 Bn 20.46 Bn 148.07 Bn
2 Johnson & Johnson 677.74 Bn 597.60 Bn 17.30 Bn 197.43 Bn
3 AbbVie 517.10 Bn 485.11 Bn 13.12 Bn 147.68 Bn
4 Merck 362.23 Bn 325.17 Bn 13.19 Bn 132.77 Bn
5 Novartis Ag 315.90 Bn 276.16 Bn 11.24 Bn 122.03 Bn
6 Astrazeneca 289.40 Bn 266.24 Bn 12.86 Bn 115.83 Bn
7 Amgen 249.90 Bn 201.56 Bn 7.58 Bn 96.05 Bn
8 Gilead Sciences 209.15 Bn 184.26 Bn 6.73 Bn 51.41 Bn
9 Pfizer 165.88 Bn 113.23 Bn 12.56 Bn 205.00 Bn
10 SpyGlass Pharma 1.25 Bn 636.40 Mn - 243.43 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 243.43 Mn
Dec 31, 2025 115.87 Mn
Dec 31, 2024 23.32 Mn
API Access

SpyGlass Pharma Liabilities and Shareholders Equity API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=liabilities-and-shareholders-equity&ticker=SGP&period=max&api_key=YOUR_API_KEY